Swiss National Bank’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$623K Hold
39,200
﹤0.01% 2249
2025
Q4
$1.03M Buy
39,200
+1,200
+3% +$31.1K ﹤0.01% 2169
2025
Q3
$859K Hold
38,000
﹤0.01% 2210
2025
Q2
$755K Hold
38,000
﹤0.01% 2239
2025
Q1
$642K Hold
38,000
﹤0.01% 2295
2024
Q4
$702K Hold
38,000
﹤0.01% 2341
2024
Q3
$826K Sell
38,000
-3,200
-8% -$71.5K ﹤0.01% 2295
2024
Q2
$808K Buy
41,200
+2,800
+7% +$58.5K ﹤0.01% 2266
2024
Q1
$833K Hold
38,400
﹤0.01% 2309
2023
Q4
$1.11M Sell
38,400
-4,100
-10% -$110K ﹤0.01% 2184
2023
Q3
$1.14M Sell
42,500
-2,800
-6% -$95.6K ﹤0.01% 2169
2023
Q2
$1.68M Buy
45,300
+4,000
+10% +$139K ﹤0.01% 2007
2023
Q1
$1.29M Sell
41,300
-6,200
-13% -$200K ﹤0.01% 2096
2022
Q4
$1.41M Buy
47,500
+800
+2% +$28.6K ﹤0.01% 2122
2022
Q3
$1.78M Buy
46,700
+800
+2% +$40.1K ﹤0.01% 1947
2022
Q2
$2.5M Hold
45,900
﹤0.01% 1762
2022
Q1
$2.87M Buy
45,900
+3,700
+9% +$244K ﹤0.01% 1815
2021
Q4
$4.25M Buy
42,200
+600
+1% +$52.7K ﹤0.01% 1569
2021
Q3
$3.74M Buy
41,600
+9,500
+30% +$863K ﹤0.01% 1662
2021
Q2
$2.96M Buy
32,100
+1,600
+5% +$128K ﹤0.01% 1841
2021
Q1
$2.95M Buy
30,500
+3,200
+12% +$330K ﹤0.01% 1772
2020
Q4
$1.42M Buy
+27,300
New +$1.14M ﹤0.01% 2113

Other funds holding FLGT

Swiss National Bank's FLGT Position: Q1 2026 in Review

Swiss National Bank held its Fulgent Genetics (FLGT) position steady in Q1 2026 at 39,200 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Swiss National Bank first reported a position in FLGT in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.25M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Swiss National Bank held 39,200 shares of Fulgent Genetics worth $623K as of Q1 2026.
  • Swiss National Bank left its Fulgent Genetics share count unchanged in Q1 2026.
  • Fulgent Genetics made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2249 holding.
  • Swiss National Bank first reported a position in Fulgent Genetics in Q4 2020 and has held it in 22 quarters since.
  • Swiss National Bank's Fulgent Genetics position peaked at $4.25M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.